BUZZ-Firefly Neuroscience advances AI tool to identify ADHD subtypes, shares jump

Reuters

Mar 13

BUZZ-<a href="https://laohu8.com/S/AIFF">Firefly Neuroscience</a> advances AI tool to identify ADHD subtypes, shares jump

** Shares of medtech firm Firefly Neuroscience AIFF.O rise 24% to $2 premarket

** Co says its AI tool aims to identify types of ADHD — a condition that can affect focus, impulse control or both — using brain scans instead of symptom checklists

** Adds that tool uses brain scans from its FDA-cleared Evoke System to study electrical activity in the brain

** Says platform is trained on more than 191,000 brain scans, the largest such database

** The technology could help doctors tailor treatments, as different types of ADHD respond differently to medication, and track whether they are working over time, co says

** YTD, shares nearly doubled in value vs. a ~67% decline in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2619194068"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2619194068\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2619194068?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 20:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619194068","market":"fut","top_or_hot":-1,"title":"BUZZ-Firefly Neuroscience advances AI tool to identify ADHD subtypes, shares jump","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/AIFF\">Firefly Neuroscience</a> advances AI tool to identify ADHD subtypes, shares jump</title></head><body><p>** Shares of medtech firm Firefly Neuroscience <span>AIFF.O</span> rise 24% to $2 premarket</p><p>** Co says its AI tool aims to identify types of ADHD — a condition that can affect focus, impulse control or both — using brain scans instead of symptom checklists</p><p>** Adds that tool uses brain scans from its FDA-cleared Evoke System to study electrical activity in the brain</p><p>** Says platform is trained on more than 191,000 brain scans, the largest such database</p><p>** The technology could help doctors tailor treatments, as different types of ADHD respond differently to medication, and track whether they are working over time, co says</p><p>** YTD, shares nearly doubled in value vs. a ~67% decline in 2025</p><p> (Reporting by Sahil Pandey in Bengaluru)</p><p> ((Sahil.Pandey@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Firefly Neuroscience advances AI tool to identify ADHD subtypes, shares jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Firefly Neuroscience advances AI tool to identify ADHD subtypes, shares jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-13 20:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/AIFF\">Firefly Neuroscience</a> advances AI tool to identify ADHD subtypes, shares jump</title></head><body><p>** Shares of medtech firm Firefly Neuroscience <span>AIFF.O</span> rise 24% to $2 premarket</p><p>** Co says its AI tool aims to identify types of ADHD — a condition that can affect focus, impulse control or both — using brain scans instead of symptom checklists</p><p>** Adds that tool uses brain scans from its FDA-cleared Evoke System to study electrical activity in the brain</p><p>** Says platform is trained on more than 191,000 brain scans, the largest such database</p><p>** The technology could help doctors tailor treatments, as different types of ADHD respond differently to medication, and track whether they are working over time, co says</p><p>** YTD, shares nearly doubled in value vs. a ~67% decline in 2025</p><p> (Reporting by Sahil Pandey in Bengaluru)</p><p> ((Sahil.Pandey@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL4N401103:1","article_id":"2619194068","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2619194068","pubTimestamp":1773404024,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Firefly Neuroscience advances AI tool to identify ADHD subtypes, shares jump** Shares of medtech firm Firefly Neuroscience AIFF.O rise 24% to $2 premarket** Co says its AI tool aims to identify types of ADHD — a condition that can affect focus, impulse control or both — using brain scans instead of symptom checklists** Adds that tool uses brain scans from its FDA-cleared Evoke System to study electrical activity in the brain** Says platform is trained on more than 191,000 brain scans, the largest such database** The technology could help doctors tailor treatments, as different types of ADHD respond differently to medication, and track whether they are working over time, co says** YTD, shares nearly doubled in value vs. a ~67% decline in 2025  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","BK4134":"信息科技咨询与其它服务","AIFF":"Firefly Neuroscience, Inc."},"translate_title":"BUZZ-Firefly Neuroscience推进人工智能工具识别ADHD亚型，股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AIFF":0.9},"content_text":"BUZZ-Firefly Neuroscience advances AI tool to identify ADHD subtypes, shares jump** Shares of medtech firm Firefly Neuroscience AIFF.O rise 24% to $2 premarket** Co says its AI tool aims to identify types of ADHD — a condition that can affect focus, impulse control or both — using brain scans instead of symptom checklists** Adds that tool uses brain scans from its FDA-cleared Evoke System to study electrical activity in the brain** Says platform is trained on more than 191,000 brain scans, the largest such database** The technology could help doctors tailor treatments, as different types of ADHD respond differently to medication, and track whether they are working over time, co says** YTD, shares nearly doubled in value vs. a ~67% decline in 2025 (Reporting by Sahil Pandey in Bengaluru) ((Sahil.Pandey@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}